drugset / Trial / NCT03546634
Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China
Phase 4
Completed
280 enrolled
Centers for Disease Control and Prevention, China
Shandong Province Centers for Disease Control and Prevention · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study aims to obtain the direct domestic IPV vaccine monitoring data for the CNBG products, and provide scientific evidence for the National Immunization Program and long-term polio vaccine immunization policy. The overall objective of this research is to determine the seroconversion rates of two reduced Sabin IPV schedules in Chinese children - a 2-dose schedule and a 3-dose schedule.
Timeline
- Start
- 2018-05-24
- Primary completion
- 2019-06-05
- Completion
- 2020-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sabin-IPV | Vaccine | — | — |